About Us
Overview
Our Leadership
Milestones
Group Companies
Zuventus
Gennova
Tillomed
Marcan
Mantra
Emcutix
Science & Innovation
Overview
Formulations
APIs
Biologics
Manufacturing
Investors
Media Centre
CSR
Career
Life At Emcure
Learning & Growth
Current Openings
Contact Us
About Us
Overview
Our Leadership
Milestones
Group Companies
Zuventus
Gennova
Tillomed
Marcan
Mantra
Emcutix
Science & Innovation
Overview
Formulations
APIs
Biologics
Manufacturing
Investors
Media Centre
CSR
Career
Life At Emcure
Learning & Growth
Current Openings
Contact Us
other-information-categorie: Disclosures under Regulation 30
Offer a wide range of services to help businesses establish.
Home
Disclosures under Regulation 30
20 June, 2025
Appointment of Secretarial Auditor of the Company for five years
Read More
20 June, 2025
Proposed Incorporation of Wholly-owned Subsidiary – 22.05.2025
Read More
20 June, 2025
Outcome of Board Meeting & Financial Results Q4 FY25
Read More
20 June, 2025
Update on USFDA inspection at API manufacturing facility located at Kurkumbh, Pune, Maharashtra, India – 18.04.2025
Read More
20 June, 2025
Allotment of Equity Shares pursuant to exercise of ESOP under Emcure Employee Stock Option Scheme 2013 – 24.03.2025
Read More
20 June, 2025
US FDA inspection at API manufacturing facility located at Kurkumbh, Pune, Maharashtra, India – 26.02.2025
Read More
20 June, 2025
Order received on 06.02.2025 by Emcure’s subsidiary
Read More
20 June, 2025
Audio recording of Earnings Call – Q3 FY25
Read More
20 June, 2025
Outcome of Board Meeting & Financial Results Q3 FY25
Read More
20 June, 2025
Orders received on 05.02.2025 by Emcure
Read More
Prev
«
01
02
03
04
05
»
Next